A few of the stocks were still below purchased price as I bought most of them around Aug 2007. I have no intention of cutting losses as I am adopting a long term approach to my investment. Furthermore I am always looking forward in collecting dividends from these stocks. In fact, I have been averaging down in batches on some of the stocks.
There was only one transaction made for the month of April.
Bought First Ship Lease Trust, average price at $1.199
I decided to average down on FSL Trust as I am impressed with the presentation slides for the latest financial results. Attached is the latest Baltic Dry Index (BDI) chart and if you see the revenue of FSL Trust for the latest quarter, you will notice that this stock is not exposed to shipping cycle risk. There was no impact on FSL Trust revenue even though the chart indicated a drastic slowdown in shipping movement at the start of the year. This is possible as FSL Trust leases ships based on long term contracts.
On the positive aspects, annualised revenue, quarterly Dividend per Unit (DPU) and number of vessels have been increasing since IPO. Recently there were acquisitions of two new oil tankers and this will definitely add more revenue for FSL Trust in future. Most importantly it is the high dividend yield that attracts investors like me.
I did not receive any dividend for the month of April.
No | Stock | Mode | Unrealised P/L |
1 | ALLCOREIT | CASH | -23.15% |
2 | ARA | CASH | -21.81% |
3 | CHINA HONGXING | CASH | 16.24% |
4 | COURAGE MAR | CASH | 5.72% |
5 | COSCOCORP | CASH | -6.37% |
6 | FIBRECHEM | CASH | -17.20% |
7 | FSL TRUST | CASH | -12.43% |
8 | GEN INT | CASH | -6.73% |
9 | INT-ROLLER ENGG | CASH | -31.89% |
10 | JAYA HLDG | CASH | -24.89% |
11 | MACQ INT INFRA | CASH | -20.24% |
12 | ROTARY ENGRG LTD | CASH | -34.00% |
13 | SINGHLDG | CASH | -48.98% |
14 | TAI SIN | CASH | -32.49% |
15 | UOB-KAY HIAN | CASH | -11.60% |
16 | VICOM | CASH | -1.88% |
17 | BH GLOBAL | CPF | -17.69% |
18 | COSCOCORP | CPF | 7.56% |
19 | SIAENGG | CPF | -10.49% |
No comments:
Post a Comment